Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Atkins, MB' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gollob, JA; Veenstra, KG; Mier, JW; Atkins, MB
      Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12

      JOURNAL OF IMMUNOTHERAPY
    2. Atkins, MB; Dutcher, J; Weiss, G; Margolin, K; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
      Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part I.IL-2-based clinical trials

      MEDICAL ONCOLOGY
    3. Dutcher, J; Atkins, MB; Margolin, K; Weiss, G; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
      Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part II: Management of IL-2 toxicity and studies with other cytokines

      MEDICAL ONCOLOGY
    4. Kilbridge, KL; Weeks, JC; Sober, AJ; Haluska, FG; Slingluff, CL; Atkins, MB; Sock, DE; Kirkwood, JM; Nease, RF
      Patient preferences for adjuvant interferon alfa-2b treatment

      JOURNAL OF CLINICAL ONCOLOGY
    5. Balch, CM; Soong, SJ; Gershenwald, JE; Thompson, JF; Reintgen, DS; Cascinelli, N; Urist, M; McMasters, KM; Ross, MI; Kirkwood, JM; Atkins, MB; Thompson, JA; Coit, DG; Byrd, D; Desmond, R; Zhang, YT; Liu, PY; Lyman, GH; Morabito, A
      Prognostic factors analysis of 17,600 melanoma patients: Validation of theAmerican Joint Committee on Cancer melanoma staging system

      JOURNAL OF CLINICAL ONCOLOGY
    6. Balch, CM; Buzaid, AC; Soong, SJ; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Gershenwald, JE; Houghton, A; Kirkwood, JM; McMasters, KM; Mihm, MF; Morton, DL; Reintgen, DS; Ross, MI; Sober, A; Thompson, JA; Thompson, JF
      Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    7. Kaser, A; Brandacher, G; Steurer, W; Kaser, S; Offner, FA; Zoller, H; Theurl, I; Widder, W; Molnar, C; Ludwiczek, O; Atkins, MB; Mier, JW; Tilg, H
      Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

      BLOOD
    8. Atkins, MB
      Interleukin-2 in metastatic melanoma: What is the current role?

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    9. Atkins, MB; Kunkel, L; Sznol, M; Rosenberg, SA
      High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: Long-term survival update

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    10. McDermott, DF; Mier, JW; Lawrence, DP; van den Brink, MRM; Clancy, MA; Rubin, KM; Atkins, MB
      A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma

      CLINICAL CANCER RESEARCH
    11. Gollob, JA; Mier, JW; Veenstra, K; McDermott, DF; Clancy, D; Clancy, M; Atkins, MB
      Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: Ability to maintain IFN-gamma induction is associated with clinical response

      CLINICAL CANCER RESEARCH
    12. Balch, CM; Buzaid, AC; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Houghton, A; Kirkwood, JM; Mihm, MF; Morton, DL; Reintgen, D; Ross, MI; Sober, A; Soong, SJ; Thompson, JA; Thompson, JF; Gershenwald, JE; McMasters, KM
      A new American Joint Committee on Cancer staging system for cutaneous melanoma

      CANCER
    13. Vannier, E; Kaser, A; Atkins, MB; Fantuzzi, G; Dinarello, CA; Mier, JW; Tilg, H
      Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy

      EUROPEAN CYTOKINE NETWORK
    14. Robertson, MJ; Cameron, C; Atkins, MB; Gordon, MS; Lotze, MT; Sherman, ML; Ritz, J
      Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer

      CLINICAL CANCER RESEARCH
    15. Hochster, H; Strawderman, MH; Harris, JE; Atkins, MB; Oken, M; Skeel, RT; Jubelirer, SJ; Parkinson, D
      Conventional dose melphalan is inactive in metastatic melanoma: results ofan Eastern Cooperative Oncology Group Study (E1687)

      ANTI-CANCER DRUGS
    16. Atkins, MB; Lotze, MT; Dutcher, JP; Fisher, RI; Weiss, G; Margolin, K; Abrams, J; Sznol, M; Parkinson, D; Hawkins, M; Paradise, C; Kunkel, L; Rosenberg, SA
      High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993

      JOURNAL OF CLINICAL ONCOLOGY
    17. Blake, SP; Weisinger, K; Atkins, MB; Raptopoulos, V
      Liver metastases from melanoma: Detection with multiphasic contrast-enhanced CT

      RADIOLOGY
    18. Alpaugh, RK; von Mehren, M; Palazzo, I; Atkins, MB; Sparano, JA; Schuchter, L; Weiner, LM; Dutcher, JP
      Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon

      MEDICAL ONCOLOGY
    19. MCDERMOTT DF; TREHU EG; MIER JW; SORCE D; RAND W; RONAYNE L; KAPPLER K; CLANCY M; KLEMPNER M; ATKINS MB
      A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR

      Clinical cancer research
    20. MCDERMOTT DF; TREHU EG; MIER JW; SORCE D; RAND W; RONAYNE L; KAPPLER K; CLANCY M; KLEMPNER M; ATKINS MB
      A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR

      Clinical cancer research
    21. ATKINS MB
      IMMUNOTHERAPY AND EXPERIMENTAL APPROACHES FOR METASTATIC MELANOMA

      Hematology/oncology clinics of North America
    22. FALKSON CI; IBRAHIM J; KIRKWOOD JM; COATES AS; ATKINS MB; BLUM RH
      PHASE-III TRIAL OF DACARBAZINE VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B VERSUS DACARBAZINE WITH TAMOXIFEN VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B AND TAMOXIFEN IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    23. WEISINGER K; BLAKE SP; ATKINS MB; RAPTOPOULOS VD
      UTILITY OF TRIPHASIC CONTRAST-ENHANCED CT IN THE DIAGNOSIS OF LIVER METASTASES FROM MALIGNANT-MELANOMA

      Radiology
    24. ATKINS MB
      INTERLEUKIN-2 IN METASTATIC MELANOMA - ESTABLISHING A ROLE

      The cancer journal from Scientific American
    25. ATKINS MB; ROBERTSON MJ; GORDON M; LOTZE MT; DECOSTE M; DUBOIS JS; RITZ J; SANDLER AB; EDINGTON HD; GARZONE PD; MIER JW; CANNING CM; BATTIATO L; TAHARA H; SHERMAN ML
      PHASE-I EVALUATION OF INTRAVENOUS RECOMBINANT HUMAN INTERLEUKIN-12 INPATIENTS WITH ADVANCED MALIGNANCIES

      Clinical cancer research
    26. SOSMAN JA; ARONSON FR; SZNOL M; ATKINS MB; DUTCHER JP; WEISS GR; ISAACS RE; MARGOLIN KA; FISHER RI; ERNEST ML; MIER J; OLEKSOWICZ L; ECKHARDT JR; LEVITT D; DOROSHOW JH
      CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY

      Clinical cancer research
    27. HILLNER BE; KIRKWOOD JM; ATKINS MB; JOHNSON ER; SMITH TJ
      ECONOMIC-ANALYSIS OF ADJUVANT INTERFERON-ALFA 2B (IFN) IN HIGH-RISK MELANOMA USING PROJECTIONS FROM ECOG (E)-1684

      European journal of cancer
    28. DAILY WJ; SCHWARTZ DA; RILEY TA; ARNOLD LJ; MARVIN WB; SCURRIA MA; HOPKINS SA; ATKINS MB; GARCIA CD; PIRRUNG MC
      DIASTEREOSELECTIVE SYNTHESIS OF 2'-DEOXY AND 2'-O-METHYL DINUCLEOSIDE(3',5')-METHYLPHOSPHONATES VIA ALKOXYMAGNESIUM CHLORIDE-MEDIATED NUCLEOSIDE COUPLING

      Nucleosides & nucleotides
    29. HILLNER BE; KIRKWOOD JM; ATKINS MB; JOHNSON ER; SMITH TJ
      ECONOMIC-ANALYSIS OF ADJUVANT INTERFERON ALFA-2B IN HIGH-RISK MELANOMA BASED ON PROJECTIONS FROM EASTERN-COOPERATIVE-ONCOLOGY-GROUP-1684

      Journal of clinical oncology
    30. DUBOIS JS; TREHU EG; MIER JW; SHAPIRO L; EPSTEIN M; KLEMPNER M; DINARELLO C; KAPPLER K; RONAYNE L; RAND W; ATKINS MB
      RANDOMIZED PLACEBO-CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITH A SOLUBLE P75 TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOGLOBULIN-G CHIMERA IN PATIENTS WITH ADVANCED MELANOMA AND RENAL-CELL CARCINOMA

      Journal of clinical oncology
    31. ATKINS MB; DUTCHER JP
      RENAL-CELL CARCINOMA

      The New England journal of medicine
    32. FALLICK ML; MCDERMOTT DF; LAROCK D; LONG JP; ATKINS MB
      NEPHRECTOMY BEFORE INTERLEUKIN-2 THERAPY FOR PATIENTS WITH METASTATICRENAL-CELL CARCINOMA

      The Journal of urology
    33. FALLICK ML; MCDERMOTT DF; LAROCK D; LONG JP; ATKINS MB
      NEPHRECTOMY BEFORE INTERLEUKIN-2 THERAPY FOR PATIENTS WITH METASTATICRENAL-CELL CARCINOMA - REPLY

      The Journal of urology
    34. LEONARD JP; SHERMAN ML; FISHER GL; BUCHANAN LJ; LARSEN G; ATKINS MB; SOSMAN JA; DUTCHER JP; VOGELZANG NJ; RYAN JL
      EFFECTS OF SINGLE-DOSE INTERLEUKIN-12 EXPOSURE ON INTERLEUKIN-12-ASSOCIATED TOXICITY AND INTERFERON-GAMMA PRODUCTION

      Blood
    35. LIEBERMAN J; SKOLNIK PR; PARKERSON GR; FABRY JA; LANDRY B; BETHEL J; KAGAN J; ATKINS MB; GRADON J; STEIN D; VIRANIKETTER N; BANACH M; SCOTT M; MEYERS J; LEE E; STANDIFORD H; FONG DM; WANG A; BEYER D
      SAFETY OF AUTOLOGOUS, EX-VIVO EXPANDED HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-SPECIFIC CYTOTOXIC T-LYMPHOCYTE INFUSION IN HIV-INFECTED PATIENTS

      Blood
    36. ROBERTSON MJ; CAMERON C; ATKINS MB; GORDON MS; LOTZE MT; SHERMAN ML; RITZ J
      IMMUNOLOGICAL EFFECTS OF INTERLEUKIN-12 ADMINISTERED BY BOLUS INTRAVENOUS-INJECTION TO PATIENTS WITH ADVANCED CANCER

      Blood
    37. TREHU EG; MIER JW; DUBOIS JS; SORCE D; KLEMPNER MS; EPSTEIN M; DINARELLO CA; SHAPIRO L; KAPPLER K; RONAYNE L; ATKINS MB
      PHASE-I TRIAL OF INTERLEUKIN-2 IN COMBINATION WITH THE SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR P75 IGG CHIMERA

      Clinical cancer research
    38. TILG H; ATKINS MB; MENG G
      INFLAMMATION-ASSOCIATED THROMBOCYTOSIS - CIRCULATING THROMBOPOIETIN DURING INTERLEUKIN-6 IMMUNOTHERAPY

      Gastroenterology
    39. KARP DD; ATKINS MB
      ADOPTIVE IMMUNOTHERAPY FOR NONSMALL CELL LUNG-CARCINOMA - A 4TH TREATMENT MODALITY, COMPLICATED RADIATION SENSITIZER, OR NONE OF THE ABOVE

      Cancer
    40. DUBOIS JS; UDELSON JE; ATKINS MB
      SEVERE REVERSIBLE GLOBAL AND REGIONAL VENTRICULAR DYSFUNCTION ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 IMMUNOTHERAPY

      Journal of immunotherapy with emphasis on tumor immunology
    41. WEISS GR; MARGOLIN KA; SZNOL M; ATKINS MB; OLEKSOWICZ L; ISAACS R; SOSMAN JA; DOROSHOW JH; TREHU EG; DUTCHER JP; FISHER RI
      A PHASE-II STUDY OF THE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-6 FOR METASTATIC RENAL-CELL CARCINOMA

      Journal of immunotherapy with emphasis on tumor immunology
    42. PARKER MG; ATKINS MB; UCCI AA; LEVEY AS
      RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS AFTER IMMUNOTHERAPY FOR CANCER

      Journal of the American Society of Nephrology
    43. TILG H; ATKINS MB; DINARELLO CA; MIER JW
      INDUCTION OF CIRCULATING INTERLEUKIN-10 BY INTERLEUKIN-1 AND INTERLEUKIN-2, BUT NOT INTERLEUKIN-6 IMMUNOTHERAPY

      Cytokine
    44. ATKINS MB
      COMBINATION CHEMOTHERAPY OF METASTATIC MELANOMA - REPLY

      Journal of clinical oncology
    45. RYAN CM; ATKINS MB; MIER JW; GELFAND JA; TOMPKINS RG
      EFFECTS OF MALIGNANCY AND INTERLEUKIN-2 INFUSION ON GUT MACROMOLECULAR PERMEABILITY

      Critical care medicine
    46. ATKINS MB; KAPPLER K; MIER JW; ISAACS RE; BERKMAN EM
      INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM

      Blood
    47. SPARANO JA; FISHER RI; WEISS GR; MARGOLIN K; ARONSON FR; HAWKINS MJ; ATKINS MB; DUTCHER JP; GAYNOR ER; BOLDT DH; DOROSHOW JH; ERNEST ML; SZNOL M; MIER JW
      PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS

      Journal of immunotherapy with emphasis on tumor immunology
    48. MARGOLIN K; ARONSON FR; SZNOL M; ATKINS MB; GUCALP R; FISHER RI; SUNDERLAND M; DOROSHOW JH; ERNEST ML; MIER JW; DUTCHER JP; GAYNOR ER; WEISS GR
      PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA

      Journal of immunotherapy with emphasis on tumor immunology
    49. HAWKINS MJ; ATKINS MB; DUTCHER JP; FISHER RI; WEISS GR; MARGOLIN KA; RAYNER AA; SZNOL M; PARKINSON DR; PAIETTA E; GAYNOR ER; BOLDT DH; DOROSHOW JH; ARONSON FR
      A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA

      Journal of immunotherapy with emphasis on tumor immunology
    50. TILG H; TREHU E; SHAPIRO L; PAPE D; ATKINS MB; DINARELLO CA; MIER JW
      INDUCTION OF CIRCULATING SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR AND INTERLEUKIN-1 RECEPTOR ANTAGONIST FOLLOWING INTERLEUKIN-1-ALPHA INFUSION IN HUMANS

      Cytokine
    51. ATKINS MB; OBOYLE KR; SOSMAN JA; WEISS GR; MARGOLIN KA; ERNEST ML; KAPPLER K; MIER JW; SPARANO JA; FISHER RI; ECKARDT JR; PEREIRA C; ARONSON FR
      MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA

      Journal of clinical oncology
    52. TILG H; SHAPIRO L; VANNIER E; POUTSIAKA DD; TREHU E; ATKINS MB; DINARELLO CA; MIER JW
      INDUCTION OF CIRCULATING ANTAGONISTS TO IL-1 AND TNF BY IL-2 ADMINISTRATION AND THEIR EFFECTS ON IL-2-INDUCED CYTOKINE PRODUCTION IN-VITRO

      The Journal of immunology
    53. GRAHAM RA; ATKINS MB; KARP DD; WAZER DE; HACKFORD AW
      LOCAL EXCISION OF RECTAL-CARCINOMA - EARLY RESULTS WITH COMBINED CHEMORADIATION THERAPY USING 5-FLUOROURACIL AND LEUCOVORIN

      Diseases of the colon & rectum
    54. TILG H; TREHU E; ATKINS MB; DINARELLO CA; MIER JW
      INTERLEUKIN-6 (IL-6) AS AN ANTIINFLAMMATORY CYTOKINE - INDUCTION OF CIRCULATING IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-P55

      Blood
    55. TREHU EG; ISNER JM; MIER JW; KARP DD; ATKINS MB
      POSSIBLE MYOCARDIAL TOXICITY ASSOCIATED WITH INTERLEUKIN-4 THERAPY

      Journal of immunotherapy with emphasis on tumor immunology
    56. SOSMAN JA; WEISS GR; MARGOLIN KA; ARONSON FR; SZNOL M; ATKINS MB; OBOYLE K; FISHER RI; BOLDT DH; DOROSHOW J; ERNEST ML; FISHER SG; MIER J; VACHINO G; CALIENDO G
      PHASE-IB CLINICAL-TRIAL OF ANTI-CD3 FOLLOWED BY HIGH-DOSE BOLUS INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND ADVANCED RENAL-CELL CARCINOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS

      Journal of clinical oncology
    57. SPARANO JA; FISHER RI; SUNDERLAND M; MARGOLIN K; ERNEST ML; SZNOL M; ATKINS MB; DUTCHER JP; MICETICH KC; WEISS GR; DOROSHOW JH; ARONSON FR; RUBINSTEIN LV; MIER JW
      RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA

      Journal of clinical oncology
    58. BRANDON EP; KOTIK AN; VACHINO G; SWACK JA; LIBBY P; JANICKA MW; ATKINS MB; MIER JW
      CULTURED HUMAN ENDOTHELIAL-CELLS EXPRESS THE 140-KD ISOFORM OF NEURALCELL-ADHESION MOLECULE (NCAM)

      International journal of immunopathology and pharmacology
    59. TILG H; SHAPIRO L; ATKINS MB; DINARELLO CA; MIER JW
      INDUCTION OF CIRCULATING AND ERYTHROCYTE-BOUND IL-8 BY IL-2 IMMUNOTHERAPY AND SUPPRESSION OF ITS IN-VITRO PRODUCTION BY IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR (P75) CHIMERA

      The Journal of immunology
    60. TILG H; PAPE D; TREHU E; SHAPIRO L; ATKINS MB; DINARELLO CA; MIER JW
      A METHOD FOR THE DETECTION OF ERYTHROCYTE-BOUND INTERLEUKIN-8 IN HUMANS DURING INTERLEUKIN-1 IMMUNOTHERAPY

      Journal of immunological methods


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 08:42:25